April 23, 2024 Experience White Deer GP-led secondary transaction and formation of continuation fund We advised White Deer on the secondary transaction and $240 million continuation fund formation
April 23, 2024 Experience Baicha Baidao HK$2.6 billion IPO We advised Baicha Baidao on its IPO and HKEX listing
April 23, 2024 Experience TScan Therapeutics $150 million stock and pre-funded warrants offering The stock is listed on the Nasdaq Global Market
April 23, 2024 Experience EyeCare Partners new refinancing transaction We advised the superpriority, first-lien and second-lien administrative agent and the fronting bank on the transaction
April 23, 2024 Experience Cohen & Steers $100 million at-the-market offering The shares are listed on the NYSE
April 22, 2024 Experience Yellowstone Real Estate Investments $185 million acquisition of 1740 Broadway We advised Yellowstone on the acquisition
April 22, 2024 Experience Intra-Cellular Therapies $500 million stock offering The shares are listed on the Nasdaq Global Select Market
April 22, 2024 Experience Avolta €500 million notes offering and cash tender offer We advised Avolta on its high-yield notes offering and tender offer
April 22, 2024 Experience Morgan Stanley $8 billion senior notes offering We advised Morgan Stanley on its SEC-registered global offering